It has been reported that the overactivated PI3K/AKT signaling pathway is one of the main causes of multidrug resistance in tumor cells [16]; therefore, targeting or blocking the expression of the PI3K/Akt signaling pathway may potentially reverse drug resistance in tumor cells. The gene discussed is AKT1; the disease is neoplasm.